John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Hyperfine
HYPR
$92.9M
| $123K | ﹤0.01% |
109,382
-12,336
| -10% | -$17.2K |
|
2877
Precision BioSciences
DTIL
$239M
| $121K | ﹤0.01% |
+11,026
| New | +$119K |
|
|
AVPTW
2878
DELISTED
AvePoint Inc Warrant
AVPTW
| $121K | ﹤0.01% |
+91,800
| New | +$113K |
|
2879
Annexon
ANNX
$980M
| $121K | ﹤0.01% |
26,583
-10,517
| -28% | -$26K |
|
|
NINE
2880
DELISTED
Nine Energy Service
NINE
| $118K | ﹤0.01% |
+44,073
| New | +$128K |
|
2881
Identive
INVE
$70.5M
| $115K | ﹤0.01% |
13,911
-38,540
| -73% | -$272K |
|
|
IMTXW
2882
DELISTED
Immatics N.V. Warrants
IMTXW
| $112K | ﹤0.01% |
38,300
| – | – |
|
2883
Arteris
AIP
$1.13B
| $111K | ﹤0.01% |
18,900
-19,306
| -51% | -$109K |
|
2884
Assembly Biosciences
ASMB
$742M
| $111K | ﹤0.01% |
+11,254
| New | +$107K |
|
|
OGI
2885
Organigram Holdings
OGI
$179M
| $110K | ﹤0.01% |
+84,008
| New | +$103K |
|
2886
American Outdoor Brands
AOUT
$136M
| $109K | ﹤0.01% |
12,937
-5,400
| -29% | -$46.4K |
|
2887
Sensus Healthcare
SRTS
$55.3M
| $108K | ﹤0.01% |
45,930
-16,238
| -26% | -$38K |
|
2888
Five Point Holdings
FPH
$365M
| $108K | ﹤0.01% |
35,278
| – | – |
|
|
GRTS
2889
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $103K | ﹤0.01% |
+50,332
| New | +$91.9K |
|
2890
XBiotech
XBIT
$69.2M
| $102K | ﹤0.01% |
25,440
-5,400
| -18% | -$21.5K |
|
|
WESTW
2891
DELISTED
Westrock Coffee Company Warrants
WESTW
| $101K | ﹤0.01% |
+44,000
| New | +$76.3K |
|
|
IMA
2892
ImageneBio Inc
IMA
$62.7M
| $100K | ﹤0.01% |
4,244
+2,433
| +134% | +$79.3K |
|
2893
Lloyds Banking Group
LYG
$87.6B
| $100K | ﹤0.01% |
41,872
-440,425
| -91% | -$943K |
|
|
SOL
2894
DELISTED
Emeren Group
SOL
| $97.3K | ﹤0.01% |
35,627
+2,830
| +9% | +$7.48K |
|
2895
Rekor Systems
REKR
$80M
| $97.2K | ﹤0.01% |
29,200
+3,000
| +11% | +$8.55K |
|
2896
Capricor Therapeutics
CAPR
$458M
| $96.3K | ﹤0.01% |
+19,700
| New | +$64.1K |
|
|
BRY
2897
PUT
DELISTED
Berry Corp
BRY
| $94.9K | ﹤0.01% |
+13,500
| New | +$101K |
|
|
DMTK
2898
DELISTED
DermTech, Inc. Common Stock
DMTK
| $93.4K | ﹤0.01% |
+53,391
| New | +$78K |
|
2899
Shengfeng Development Ltd
SFWL
$73.4M
| $93.2K | ﹤0.01% |
+31,700
| New | +$354K |
|
2900
Copel
ELPC
$8.39B
| $91K | ﹤0.01% |
+11,559
| New | +$91K |
|
Similar funds
John Overdeck's Q4 2023 Portfolio in Review
As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- John Overdeck opened 550 new positions and closed 366 in Q4 2023.
- John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.